HARRIGAN EDMUND (CIK 1177917) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy INCY (255 shares), Buy INCY (1,642 shares), Buy ACAD (8,107 shares), Buy INCY (269 shares), Buy INCY (245 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | INCYTE CORP (INCY) | Director | Buy | 255 | $28,907 |
| 2026-06-10 | INCYTE CORP (INCY) | Director | Buy | 1,642 | $0 |
| 2026-06-01 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Buy | 8,107 | $0 |
| 2026-04-02 | INCYTE CORP (INCY) | Director | Buy | 269 | $25,318 |
| 2026-01-05 | INCYTE CORP (INCY) | Director | Buy | 245 | $24,199 |
| 2025-10-02 | INCYTE CORP (INCY) | Director | Buy | 289 | $24,510 |
| 2025-07-02 | INCYTE CORP (INCY) | Director | Buy | 367 | $24,993 |
| 2025-06-12 | INCYTE CORP (INCY) | Director | Buy | 2,518 | $0 |
| 2025-06-02 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Buy | 9,387 | $0 |
| 2025-04-02 | INCYTE CORP (INCY) | Director | Buy | 363 | $21,980 |
Source: SEC Form 4 filings · as of 2026-07-02